Newsroom
Sorted by: Latest
-
LTM Collaborates with IBM and Red Hat on Lightwell to Advance AI-Driven Open-Source Software Remediation
MUMBAI, India--(BUSINESS WIRE)--LTM today announced that it has collaborated with IBM and Red Hat on Lightwell to advance AI-driven open-source software remediation....
-
Pensions & Investments Names Elizabeth Dillon, Pictet Asset Management, One of Its 2026 Most Influential Women in Institutional Investing
NEW YORK--(BUSINESS WIRE)--Pensions & Investments has named Elizabeth Dillon, Chief Executive Officer of Pictet Asset Management (USA), as one of the Most Influential Women in Institutional Investing 2026. Now in its fourth year, the list recognizes the distinguished women who have made a meaningful impact on the industry. "I'm honored to be recognized by Pensions & Investments alongside so many women I admire across our industry," said Dillon. "Building a team and a business has been a...
-
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Treatment of Multiple Hematologic and Solid Malignancies
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Crossbow dosed the first participant in its Phase 1 clinical trial of CBX-663, for the treatment of multiple hematologic and solid tumors....
-
Stuck in Agentic AI Pilot Purgatory? UiPath Survey Points to Orchestration as Key to Scaling Enterprise Deployments
NEW YORK--(BUSINESS WIRE)--UiPath released a new global report on the state of agentic AI deployments, coding agents, and business orchestration....
-
NUBURU Announces Reinstatement of Trading on NYSE American
DENVER--(BUSINESS WIRE)--NUBURU, Inc. (OTC Pink: BURUD) (“NUBURU” or the “Company”), a next-generation dual-use Defense & Security integrated platform company, today announced that, following notification from NYSE Regulation, trading in the Company’s common stock is scheduled to resume on NYSE American on Monday, September 14, 2026, under the ticker symbol “BURU.” The Company’s common stock will continue to use CUSIP number 67021W509. The resumption follows NUBURU’s 1-for-40 reverse stock...
-
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C...
-
Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Raises $275 Million in Series F Financing to Advance Precision Genetic Medicines Neurology Pipeline...
-
Shionogi to Showcase Advancements Across its Infectious Disease Portfolio at IDWeek 2026
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will present findings from across its broad anti-infective portfolio at IDWeek 2026 (October 21-24, 2026), in Washington, D.C. Data highlights at IDWeek 2026 include an oral presentation featuring a subpopulation analysis from the global Phase 3 SCORPIO-PEP trial, a rapid-fire session focused on ventilator-ass...
-
XL Batteries Enters into a Memorandum of Understanding with ENEOS Holdings, Inc. to Advance Long-Duration Energy Storage
MARLBOROUGH, Mass.--(BUSINESS WIRE)--XL Batteries, an energy storage company commercializing a revolutionary, safe, low-cost, and reliable grid-scale battery, today announced it has entered into a Memorandum of Understanding (MOU) with ENEOS Holdings, Inc. (hereinafter "ENEOS HD"), the parent company behind one of Japan’s largest energy firms. The agreement establishes a framework for long-term collaboration to advance XL Batteries’ technology and accelerate commercial deployment. As grids arou...
-
Vision Ridge Partners Strengthens Portfolio Operations with Addition of Jason O’Briant as Head of Portfolio Talent
NEW YORK--(BUSINESS WIRE)--Vision Ridge Partners (“Vision Ridge” or the “Firm”), a global sustainable real assets investor, today announced that Jason O’Briant has joined the Firm as Head of Portfolio Talent. In this newly created role, he will build and lead a value-creating talent function dedicated to Vision Ridge’s portfolio companies. Mr. O’Briant has more than 30 years of experience across three vantage points of value to Vision Ridge, including spending over 20 years inside global operat...